India to South Africa: Glimepiride Export Trade Route

The India to South Africa Glimepiride corridor is one of India's established pharmaceutical export routes, with 96 shipments documented worth a combined $3.7M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's glimepiride manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $38.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 31.4%, placing it at rank #18 among India's top glimepiride export destinations globally.

On the import side, key buyers of Indian glimepiride in South Africa include NA, OETHMAAN BIOSIMS (PTY) LTD.,, Accord Healthcare c/o UPD Lea Glen and 14 others. NA is the single largest importer with 33 shipments valued at $2.8M USD.

India's glimepiride exports to South Africa are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 45 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, V S INTERNATIONAL PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 90% of total trade value on this route. The average shipment value of $38.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as glimepiride 1mg tablets(81140x2x14's pack =2271920 tablets) and harmless medicines: glimepiride 4mg tablets (glimepiride) [2x14's per pack], suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 33 shipments worth $2.8M USD — representing 76% of all glimepiride imports from India on this route. A total of 17 buyers are active on this corridor.